share_log

Passage Bio Tapped Kathleen Borthwick as CFO, Effective March 1

Passage Bio Tapped Kathleen Borthwick as CFO, Effective March 1

Passage Bio 聘请凯瑟琳·博思威克担任首席财务官,自 3 月 1 日起生效
Moomoo 24/7 ·  03/04 07:07
  • Appointed Kathleen Borthwick as Chief Financial Officer, effective March 1, 2024: Ms. Borthwick previously served as the company's Senior Vice President, Finance and Interim CFO and brings 25 years of pharmaceutical and biotech strategic financial leadership experience.
  • 任命凯瑟琳·博思威克为首席财务官,自2024年3月1日起生效:博思威克女士曾担任公司高级副总裁、财务和临时首席财务官,拥有25年的制药和生物技术战略财务领导经验。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发